Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Increased levels of glutamate in brains from patients with mood disorders.

Hashimoto K, Sawa A, Iyo M.

Biol Psychiatry. 2007 Dec 1;62(11):1310-6. Epub 2007 Jun 15.

PMID:
17574216
2.

Dysregulation of GABAergic neurotransmission in mood disorders: a postmortem study.

Bielau H, Steiner J, Mawrin C, Trübner K, Brisch R, Meyer-Lotz G, Brodhun M, Dobrowolny H, Baumann B, Gos T, Bernstein HG, Bogerts B.

Ann N Y Acad Sci. 2007 Jan;1096:157-69.

PMID:
17405927
3.

Reductions in cholesterol and synaptic markers in association cortex in mood disorders.

Beasley CL, Honer WG, Bergmann K, Falkai P, Lütjohann D, Bayer TA.

Bipolar Disord. 2005 Oct;7(5):449-55.

PMID:
16176438
4.

A postmortem study of glycine and its potential precursors in chronic schizophrenics.

Kurumaji A, Watanabe A, Kumashiro S, Semba J, Toru M.

Neurochem Int. 1996 Sep;29(3):239-45.

PMID:
8885282
5.

Changes in plasma amino acids after electroconvulsive therapy of depressed patients.

Palmio J, Huuhka M, Saransaari P, Oja SS, Peltola J, Leinonen E, Suhonen J, Keränen T.

Psychiatry Res. 2005 Dec 15;137(3):183-90. Epub 2005 Nov 17.

PMID:
16297983
6.

Increased serum levels of glutamate in adult patients with autism.

Shinohe A, Hashimoto K, Nakamura K, Tsujii M, Iwata Y, Tsuchiya KJ, Sekine Y, Suda S, Suzuki K, Sugihara G, Matsuzaki H, Minabe Y, Sugiyama T, Kawai M, Iyo M, Takei N, Mori N.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1472-7. Epub 2006 Jul 24. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):590.

PMID:
16863675
7.

Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states.

Hosokawa T, Momose T, Kasai K.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):243-50. doi: 10.1016/j.pnpbp.2008.11.014. Epub 2008 Dec 3.

PMID:
19100808
8.

State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.

Wakabayashi Y, Uchida S, Funato H, Matsubara T, Watanuki T, Otsuki K, Fujimoto M, Nishida A, Watanabe Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jul 1;32(5):1199-205. doi: 10.1016/j.pnpbp.2008.03.005. Epub 2008 Mar 15.

PMID:
18430502
9.

Correlation between plasma levels of glutamate, alanine and serine with severity of depression.

Mitani H, Shirayama Y, Yamada T, Maeda K, Ashby CR Jr, Kawahara R.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1155-8. Epub 2006 May 16.

PMID:
16707201
10.

A preliminary study of free amino acids in the postmortem temporal cortex from Alzheimer-type dementia patients.

Arai H, Kobayashi K, Ichimiya Y, Kosaka K, Iizuka R.

Neurobiol Aging. 1984 Winter;5(4):319-21.

PMID:
6152305
11.

GABA and glutamate systems as therapeutic targets in depression and mood disorders.

Kendell SF, Krystal JH, Sanacora G.

Expert Opin Ther Targets. 2005 Feb;9(1):153-68. Review.

PMID:
15757488
12.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
13.

Alterations in D-amino acid levels in the brains of mice and rats after the administration of D-amino acids.

Morikawa A, Hamase K, Inoue T, Konno R, Zaitsu K.

Amino Acids. 2007 Jan;32(1):13-20. Epub 2006 Jun 7.

PMID:
16755370
14.

Brain amino acid abnormalities in kidney disease and diabetes mellitus.

Schmidt P, Musshoff F, Hilgers C, Steins N, Bürrig KF, Jacob B, Daldrup T, Madea B.

Forensic Sci Int. 2004 Jun 10;142(2-3):221-7.

PMID:
15172081
15.

Temporal patterns of interstitial pyruvate and amino acids after subarachnoid haemorrhage are related to the level of consciousness--a clinical microdialysis study.

Zetterling M, Hillered L, Samuelsson C, Karlsson T, Enblad P, Ronne-Engström E.

Acta Neurochir (Wien). 2009 Jul;151(7):771-80; discussion 780. doi: 10.1007/s00701-009-0384-4. Epub 2009 May 9.

PMID:
19430719
16.

Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.

Uezato A, Meador-Woodruff JH, McCullumsmith RE.

Bipolar Disord. 2009 Nov;11(7):711-25. doi: 10.1111/j.1399-5618.2009.00752.x.

PMID:
19839996
17.

Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil.

Gos T, Günther K, Bielau H, Dobrowolny H, Mawrin C, Trübner K, Brisch R, Steiner J, Bernstein HG, Jankowski Z, Bogerts B.

J Affect Disord. 2009 Feb;113(1-2):45-55. doi: 10.1016/j.jad.2008.04.021. Epub 2008 Jun 6.

PMID:
18538859
18.

[Role of glutamate transporters in the pathophysiology of major mental illnesses].

Tanaka K.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2009 Aug;29(4):161-4. Review. Japanese.

PMID:
19764483
19.

Brain levels of GABA, glutamate and aspartate in sociable, aggressive and timid mice: an in vivo microdialysis study.

Sustková-Fiserová M, Vávrová J, Krsiak M.

Neuro Endocrinol Lett. 2009 Mar;30(1):79-84.

PMID:
19300401
20.

Classifying mood disorders by age-at-onset instead of polarity.

Benazzi F.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Feb 1;33(1):86-93. doi: 10.1016/j.pnpbp.2008.10.007. Epub 2008 Oct 27.

PMID:
18992784

Supplemental Content

Support Center